Riskpilot← Back to searchSign inGet full accessTaberman Målat & Annat AB
ABActiveOrg 5566368238Olof Palmes Gata 14Medical specialists activities · NACE 8622Est. 20021-4 employees
Revenue 2024
SEK 526K
+95% vs 2023
EBITDA margin
88.8%
+137% vs 2023
Equity ratio
70.1%
Financial strength
Net profit 2024
SEK 278K
+77% vs 2023
| Revenue | SEK 526K | +95% |
| EBITDA | SEK 467K | +137% |
| Net profit | SEK 278K | +77% |
| Total assets | SEK 1,2M | +68% |
| Equity | SEK 846K | +49% |
| Employees | — | — |
Legal name
Taberman Målat & Annat AB
Org number
5566368238
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
20 december 2002
Share capital
SEK 175 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva tillverkning och försäljning av konsthantverk och inredning. Sjukvård, läkarkonsultuppdrag, undervisning, utbildning och handledning i medicinsk och angränsande verksamhet samt därmed förenlig verksamhet.
Address
Olof Palmes Gata 14
Phone
+4686646938
Email
mans.edlund@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 307 | 299 | 215 | 269 | 526 |
| Staff expenses | — | — | −5 | −5 | −5 |
| EBITDA | 146 | 189 | 107 | 197 | 467 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 146 | 189 | 107 | 197 | 467 |
| Net financials | — | 9 | 6 | 1 | 0 |
| Profit before tax | 146 | 146 | 85 | 198 | 351 |
| Tax | −36 | −33 | −20 | −41 | −74 |
| Net profit | 110 | 113 | 65 | 157 | 278 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 378 | 500 | 628 | 719 | 1 207 |
| Equity | 303 | 347 | 411 | 568 | 846 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 75 | 101 | 137 | 70 | 165 |
| Total debt | 75 | 101 | 137 | 70 | 165 |
EBITDA margin
88.8%
This company
15.8%
Market median
+462% vs market
20202024
Equity ratio
70.1%
This company
38.2%
Market median
+84% vs market
20202024
Return on equity
32.8%
This company
18.4%
Market median
+78% vs market
20202024
Net profit margin
52.8%
This company
8.1%
Market median
+552% vs market
20202024
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MG Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Taberman Målat & Annat AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Måns Gustaf Edlund | Chief Executive Officer | 0 companies |
| Anneli Margareta Taberman Edlund | Board of Directors | 0 companies |